In Vivo Targeting of Escherichia coli with Vancomycin-Arginine

The ability of vancomycin-arginine (V-r) to extend the spectrum of activity of glycopeptides to Gram-negative bacteria was investigated. Its MIC towards Escherichia coli, including β-lactamase expressing Ambler classes A, B, and D, was 8 to 16 μg/ml. Addition of 8 times the MIC of V-r to E. coli was...

Descripción completa

Detalles Bibliográficos
Autores principales: Neville, Lewis F., Shalit, Itamar, Warn, Peter A., Scheetz, Marc H., Sun, Jiuzhi, Chosy, Madeline B., Wender, Paul A., Cegelski, Lynette, Rendell, Jacob T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097466/
https://www.ncbi.nlm.nih.gov/pubmed/33468474
http://dx.doi.org/10.1128/AAC.02416-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097466/
https://www.ncbi.nlm.nih.gov/pubmed/33468474
http://dx.doi.org/10.1128/AAC.02416-20

Ejemplares similares